Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,186.00
Bid: 12,184.00
Ask: 12,188.00
Change: -230.00 (-1.85%)
Spread: 4.00 (0.033%)
Open: 12,234.00
High: 12,238.00
Low: 12,172.00
Prev. Close: 12,416.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Wed, 09th Dec 2020 16:08

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Wizz Air Holdings PLC - Budapest-based budget airline - Hires Robert Carey as president, starting June 14 next year, to oversee operations and commercial functions. Carey has been chief commercial & strategy officer for rival carrier easyJet PLC since 2017, having started at America West Airlines followed by Delta Airlines and a 10-year stint at McKinsey & Co. Wizz also hires Michael Delehant as executive vice president and chief operations officer, reporting to Carey. Delehant joins from Vueling, the Spanish low-cost airline owned by International Consolidated Airlines Group SA, where he has been chief strategy & network officer. He starts at Wizz on April 1.

----------

Cenkos Securities PLC - London-based stock broker and company advisor - Jim Durkin will retire as chief executive in March of next year, after having returned to Cenkos in 2019. That was a difficult time for UK stockbrokers, Cenkos notes, and Durkin "kept the company profitable, led the restructuring of the board and further strengthened governance". Julian Morse, an executive director and head of the Growth Companies Team, will replace Durkin as CEO. Cenkos says Morse is a founding member of the Growth Companies Team and has led it since 2016. Cenkos also promotes Jeremy Osler, co-head of Corporate Finance & general counsel, to the board as an executive director. Osler joined Cenkos in 2016.

----------

London Stock Exchange Group PLC - trading and clearing operator and index calculator - Proposes Martin Brand, Erin Brown and Douglas Steenland as board directors. The appointments are part of LSEG's acquisition of market data and trading platform provider Refinitiv, following which the shareholders of Refinitiv will have the right to nominate three non-executive directors for as long as they continue to hold at least 25% of LSEG. Brand and Steenland will represent Blackstone, and Brown will represent Thomson Reuters. Brand is a senior managing director and co-head of US Acquisitions for Blackstone's Private Equity Group. Steenland is a a senior adviser to the Blackstone Private Equity Group. Brown is head of Finance for the Thomson Reuters Corporates segment. LSEG expects the Refinitiv acquisition to complete in the first quarter of next year.

----------

Aviva PLC - London-based life and general insurer - Hires Pippa Lambert as independent non-executive director, starting January 1. Lambert was global head of Human Resources at Deutsche Bank AG and before that head of Reward at Royal Bank of Scotland.

----------

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Hires Christopher Brinsmead as director. Brinsmead was president of AstraZeneca UK & Ireland, part of AstraZeneca PLC, until 2010 and before that president of the Association of the British Pharamaceutical Industry.

----------

Network International Holdings PLC - Middle East-focused payment solutions provider - Hires Diane Radley and Monique Shivanandan as independent non-executive directors, starting January 1. Radley led the Transaction Services Group at PwC South Africa. She also was CEO of Old Mutual Investment Group from 2011 to 2016, having been finance director prior to that. Shivanandan is chief information officer at property and casualty insurance firm Chubb Ltd and also a non-executive director for JP Morgan Securities in the UK.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.